J. Ferry

J. Ferry, D. Batts, B. D. Herman, 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

The practical impact of altered dosing on perampanel plasma concentrations: Pharmacokinetic modeling from clinical studies

J. Ferry, Hai-chen Yang, R. Fain, 2014, Epilepsy & Behavior.

Absence of Liver Toxicity in Perampanel-Treated Subjects: Pooled results from partial seizure phase III perampanel clinical studies

J. Ferry, Hai-chen Yang, A. Laurenza, 2015, Epilepsy Research.

Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12 Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and Efficacy

J. Ferry, J. Renfroe, A. Laurenza, 2019, Journal of child neurology.

Pharmacokinetics, Pharmacodynamics, and Safety of the Dual Orexin Receptor Antagonist Lemborexant: Findings From Single‐Dose and Multiple‐Ascending‐Dose Phase 1 Studies in Healthy Adults

J. Ferry, M. Moline, J. Aluri, 2020, Clinical pharmacology in drug development.

The effect of UVB-induced erythema on the percutaneous absorption of minoxidil from an aqueous topical solution.

J. Ferry, T. Hunt, J. H. Shepard, 1990, Biopharmaceutics & drug disposition.

Patent Number : 45 Date of Patent : 5 , 646 , 174 Jul

J. Ferry, J. G. Wagner, J. Hageman, 2017 .

Drug and vehicle deposition from topical applications: use of in vitro mass balance technique with minoxidil solutions.

N. Weiner, G. Flynn, J. Ferry, 1992, Journal of pharmaceutical sciences.

ELENBECESTAT, A NOVEL ORAL BACE INHIBITOR, HAS NO CLINICALLY MEANINGFUL EFFECT ON QTC INTERVAL UP TO A SUPRATHERAPEUTIC DOSE OF 200 MG

J. Ferry, B. Albala, B. Darpo, 2017, Alzheimer's & Dementia.

ELENBECESTAT PHARMACOKINETIC DRUG-DRUG INTERACTIONS INDICATED NO DOSAGE ADJUSTMENTS REQUIRED FOR MOST CONCOMITANT TREATMENTS

J. Ferry, B. Albala, R. Lai, 2017, Alzheimer's & Dementia.

Multiple‐dose Cimetidine Administration Does Not Influence the Single‐dose Pharmacokinetics of Quinapril and Its Active Metabolite (CI‐928)

J. Ferry, A. M. Horvath, A. Sedman, 1988, Journal of clinical pharmacology.

Concentration–Response Modeling of ECG Data From Early‐Phase Clinical Studies as an Alternative Clinical and Regulatory Approach to Assessing QT Risk — Experience From the Development Program of Lemborexant

Borje Darpo, Takashi Yoshinaga, Nancy Hall, 2017, Journal of clinical pharmacology.

Potential protein-binding displacement interactions with perampanel: An in vitro analysis

J. Ferry, A. Laurenza, B. Gidal, 2019, Epilepsy Research.

Michaelis-Menten elimination kinetics: areas under curves, steady-state concentrations, and clearances for compartment models with different types of input.

J. Wagner, J. Ferry, G. J. Szpunar, 1985, Biopharmaceutics & drug disposition.

Exact mathematical equivalence of the venous equilibration ("well-stirred") model, the sinusoidal perfusion ("parallel-tube") model, and a specific two-compartment open model.

J. Wagner, J. Ferry, G. J. Szpunar, 1984, Drug metabolism and disposition: the biological fate of chemicals.

A pharmacokinetic model for prednisone after infusion to steady-state in the rabbit.

J. Wagner, J. Ferry, 1985, Biopharmaceutics & drug disposition.

Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers

J. Ferry, M. Sarkar, M. Adams, 1998, Biopharmaceutics & drug disposition.

Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution.

J. Ferry, J. H. Shepard, G. J. Szpunar, 1990, Journal of pharmaceutical sciences.

Concentration–effect relationships with perampanel in patients with pharmacoresistant partial‐onset seizures

J. Ferry, B. Gidal, O. Majid, 2013, Epilepsia.

Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses

J. Ferry, W. Colburn, I. Bekersky, 1988, Journal of clinical pharmacology.

Absorption of flurbiprofen through human buccal mucosa.

J. Wagner, J. Ferry, J. Hageman, 1991, Journal of pharmaceutical sciences.

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ‐secretase modulator, E2212, in healthy human subjects

J. Ferry, E. Schuck, Yanke Yu, 2014, Journal of clinical pharmacology.

Pharmacokinetic/pharmacodynamic analysis of adjunctive perampanel in subjects with partial‐onset seizures

J. Ferry, A. Laurenza, O. Takenaka, 2018, Acta neurologica Scandinavica.

The non‐linear pharmacokinetics of prednisone and prednisolone

J. Wagner, J. Ferry, 1988, Biopharmaceutics & drug disposition.

Effect of minoxidil concentration on the deposition of drug and vehicle into the skin

N. Weiner, G. Flynn, J. Ferry, 1993 .

Population Pharmacokinetic/Pharmacodynamic Analyses of Avatrombopag in Patients With Chronic Liver Disease and Optimal Dose Adjustment Guide With Concomitantly Administered CYP3A and CYP2C9 Inhibitors

J. Ferry, Maiko Nomoto, Ziad Hussein, 2018, Journal of clinical pharmacology.

Single- and Multiple-dose Pharmacokinetics of a Lorcaserin Extended-release Tablet.

J. Ferry, A. Kristensen, Michael E. Morgan, 2016, Clinical therapeutics.

Impact of perampanel on pharmacokinetics of concomitant antiepileptics in patients with partial‐onset seizures: pooled analysis of clinical trials

J. Ferry, A. Laurenza, O. Majid, 2016, British journal of clinical pharmacology.

Use of extended-release and immediate-release anti-seizure medications with a long half-life to improve adherence in epilepsy: A guide for clinicians

J. Ferry, B. Gidal, L. Reyderman, 2021, Epilepsy & Behavior.

Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers

J. Ferry, H. Karnes, W. Garnett, 1998, Biopharmaceutics & drug disposition.